|
PRIM1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.328500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.440000E-02 |
| Normal-vs-Stage2 |
3.640200E-02 |
| Normal-vs-Stage3 |
5.467800E-02 |
| Normal-vs-Stage4 |
8.076500E-02 |
| Stage1-vs-Stage2 |
2.805200E-01 |
| Stage1-vs-Stage3 |
5.390000E-01 |
| Stage1-vs-Stage4 |
5.733000E-01 |
| Stage2-vs-Stage3 |
5.765400E-01 |
| Stage2-vs-Stage4 |
6.825000E-01 |
| Stage3-vs-Stage4 |
9.307400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.737700E-02 |
| Normal-vs-AfricanAmerican |
7.185600E-02 |
| Normal-vs-Asian |
2.779800E-01 |
| Caucasian-vs-AfricanAmerican |
4.972600E-01 |
| Caucasian-vs-Asian |
6.700000E-01 |
| AfricanAmerican-vs-Asian |
3.956400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.684000E-02 |
| Normal-vs-Female |
6.953800E-02 |
| Male-vs-Female |
3.387200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.005400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.137900E-02 |
| Normal-vs-Age(61-80Yrs) |
4.107700E-02 |
| Normal-vs-Age(81-100Yrs) |
9.386400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.593390E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.297200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.349400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.848800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.121000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.928400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.561000E-01 |
| Classical-VS-Follicular |
2.525600E-02 |
| Classical-VS-Other |
8.108400E-01 |
| Classical-VS-Normal |
1.620000E-01 |
| Tall-VS-Follicular |
3.562200E-01 |
| Tall-VS-Other |
9.013000E-01 |
| Tall-VS-Normal |
1.239220E-01 |
| Follicular-VS-Other |
6.076600E-01 |
| Follicular-VS-Normal |
6.617200E-03 |
| Other-VS-Normal |
4.728200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.849900E-02 |
| Normal-vs-N1 |
4.102800E-03 |
| N0-vs-N1 |
2.005200E-01 |
|
|
